NIDA Avant-Garde-Medications Development Award winners announced
September 28th, 2011
Scientists proposing to develop vaccines against methamphetamine and nicotine have been selected to receive NIDA’s second Avant-Garde Awards for Innovative Medication Development Research. The two scientists, Dr. Thomas Kosten, of Baylor College of Medicine, Houston, and Dr. Peter Burkhard, of the University of Connecticut, Storrs, will each receive $500,000 per year for five years to support their research, according to the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
Related posts:
- First NIDA Avant-Garde Awards for Medications Development Research A potential immunotherapy, a new gene therapy, an enzyme inhibitor, and a compound originally isolated from a Chinese herb are among the latest approaches scientists are proposing to treat addiction. The recipients of the first-ever Avant-Garde Awards for Innovative Medication Development Research by the National Institute on Drug Abuse (NIDA), part of the National Institutes […]...
- HIV/AIDS researcher David Ho wins NIDA’s 2011 Avant-Garde Award The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced today that Dr. David Ho of the Aaron Diamond AIDS Research Center in New York, NY, has been selected as the 2011 recipient of the NIDA Avant-Garde Award for HIV/AIDS Research....
- NIDA NewsScan #67 To coincide with the 2010 International AIDS Conference in Vienna, NIDA has written a special issue of NewsScan on HIV/AIDS which features recent articles on the connection between drug abuse and HIV/AIDS and prevention and treatment strategies, authored by researchers supported by NIDA and other leading research organizations....
- Medicare Card, Scientists Identify Markers, Human Breast Cancer Cells, Linked to Development of an Aggressive, But Less Common Form of Breast Cancer Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. In this preliminary study, estrogen-negative breast cancer developed when three markers, CD44+, CD49fhi, and CD133hi were present simultaneously on the surface of human cells taken from breast cancer patients and transplanted into a […]...
- A statement from the NIH Director, Francis S. Collins, M.D., Ph.D., on the Presidential Early Career Award for Scientists and Engineers (PECASE) recipients Eighteen NIH grantees and two intramural scientists have been selected by the White House Office of Science and Technology Policy to be among this year’s 120 researchers to receive this presidential award, the nation’s highest honor for scientists at the beginning of their professional careers....
- NIDA, Federal Partners, Launch National Drug Facts Week Expanding on the success of its online Drug Facts Chat Day, the National Institute on Drug Abuse (NIDA) today announced it is launching National Drug Facts Week, a new national awareness week designed to bring together teens and scientific experts to discuss the facts about drug abuse. NIDA is a component of the National Institutes […]...
- Director, Francis S. Collins, M.D., Ph.D., recognizes 20 NIH recipients of the Presidential Early Career Award for Scientists and Engineers (PECASE) PECASE is the nation’s highest honor for scientists at the beginning of their professional careers. Since the program began in 1996, NIH has funded a total of 193 PECASE recipients....
- New technique identifies first events in tumor development A novel technique that enables scientists to measure and document tumor-inducing changes in DNA is providing new insight into the earliest events involved in the formation of leukemias, lymphomas and sarcomas, and could potentially lead to the discovery of ways to stop those events....
- Medicare Card, Non-profits sign research and development agreement The National Institutes of Health today announced an agreement with two non-profit organizations to accelerate the development of potential clinical therapies for rare blood cancers....
- Medicare, Common Mechanisms of Drug Abuse and Obesity Some of the same brain mechanisms that fuel drug addiction in humans accompany the emergence of compulsive eating behaviors and the development of obesity in animals, according to research funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health....
- U.S. Commerce Secretary Gary Locke Announces Winners of i6 Challenge U.S. Commerce Secretary Gary Locke today announced the winners of the i6 Challenge, a new $12 million innovation competition led by the U.S. Department of Commerce’s Economic Development Administration (EDA), in partnership with the National Institutes of Health (NIH) and the National Science Foundation (NSF). Locke made the announcement during his keynote remarks at an […]...
- Bypass surgery, medications both options to be considered for heart failure patients with coronary artery disease A new study found that coronary artery bypass surgery added to medical therapy for selected chronic heart failure patients offered benefits over medical therapy alone. The combination of the two treatment approaches reduced the combined rate of deaths and heart-related hospital stays by 15 percent, although the total number of deaths between the two groups […]...
- $550 million budget deficit will not slow down the development of SustiNet development of SustiNet...
- Therapeutics for Rare and Neglected Diseases Program announces next round of drug development projects Researchers will begin drug development projects for rare and neglected diseases that include potential treatments for a musculoskeletal disorder, a cognitive dysfunction disorder, a virus that affects the central nervous system of newborns, a parasitic worm infection, a form of muscular dystrophy and a rare lung disease....
- NHGRI funds development of revolutionary DNA sequencing technologies Researchers today received more than $14 million in grants to develop DNA sequencing technologies that will rapidly sequence a person’s genome for $1000 or less. The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, awarded the grants to enable the everyday use of DNA sequencing technologies by biomedical researchers and […]...
Posted in MedicareCard Replacement | Tags: MEDICARE CARD